PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmaceutics, Faculty of Science, Utrecht University, Utrecht, the Netherlands.\', \'Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, USA.\', \'Preclinical Services Cell & Gene Therapy, Lonza BV, Maastricht, the Netherlands.\', \'AL Associates LLC, West Chester, PA, USA.\', \'Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, the Netherlands. Electronic address: w.jiskoot@lacdr.leidenuniv.nl.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0022-3549(20)30744-910.1016/j.xphs.2020.11.015
?:hasPublicationType
?:journal
  • Journal of pharmaceutical sciences
is ?:pmid of
?:pmid
?:pmid
  • 33242452
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.984
?:rankingScore_hIndex
  • 149
is ?:relation_isRelatedTo_publication of
?:title
  • The Science is There: Key Considerations for Stabilizing Viral Vector-Based Covid-19 Vaccines.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33242452>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33242452>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all